GIFFIN BRETT A. (Chief Commercial Officer) exercised options at T2 BIOSYSTEMS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/28/2023ACC: 0000950170-23-066398
Officer· Chief Commercial Officer
Since Nov 2021
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
33.00 acquired · 33.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+33.00
Price / share
—
Trade value
—
% of position
106.5%
11/8/2023
31.00→64.00
Total
Net shares
+33.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/8/2023 | M · Option Exercise | +33.00 | — | — | 106.5% | 31.00 | 64.00 |
| Total | +33.00 | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
33.00 shares
Shares
−33.00
Strike price
Held after
34.00
Exercisable
—
11/8/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock33.00 shares | 11/8/2023 | M · Option Exercise | −33.00 | — | 34.00 |